Background/objective: Acne vulgaris is one of the most common diseases of the youth. Systemic isotretinoin is the only drug which acts on all of the etiopathogenic mechanisms of acne. Isotretinoin has some well-known side effects. Besides these, there is a suspicion whether it affects fertility or not. Previously, we conducted a study about isotretinoin's effect on ovarian reserve which showed deteriorative reserve. In this study, we aimed to evaluate the long-term effects of systemic isotretinoin on female fertility.
Materials And Methods: Of the 82 female patients who were enrolled in the first study, 79 patients were included in this study. Twelve months after the end of systemic isotretinoin treatment, patients were reevaluated by using the same parameters which include anti-Mullerian hormone (AMH), ovarian volume (OV), antral follicle count (AFC), follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, free testosterone and total testosterone.
Results: The changes in the mean AMH, OV and AFC were statistically significant between the sixth and eighteenth months (the end of systemic isotretinoin treatment and 12 months treatment free). The mean AMH, OV and AFC values at the beginning and at the 18th month were statistically similar.
Conclusion: The deteriorative effects of systemic isotretinoin treatment on ovarian reserve, which can be accepted as an indicator of female fertility, diminish in time.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3109/15569527.2016.1172234 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Use of oral retinoids in the perioperative period by surgical specialty: a literature review.
Arch Dermatol Res
January 2025
Department of Dermatology, Wright State University Boonshoft School of Medicine, Dayton, OH, USA.
Article Synopsis
- This review analyzes the effects of oral retinoids like isotretinoin on wound healing across different surgical fields.
- It raises concerns about the common practice of stopping these medications before surgery, suggesting it's not always necessary based on current research.
- The article calls for personalized decisions regarding retinoid use before surgery and highlights the importance of collaboration between dermatologists and surgeons for better perioperative care.
Oral Isotretinoin-Associated Ocular Effects and Risk Factors: A Cross-Sectional Study.
Clin Ophthalmol
December 2024
Faculty of Medicine, Jazan University, Jazan, Saudi Arabia.
Article Synopsis
- This study examines the effects of oral isotretinoin on eye health in patients with acne vulgaris, highlighting issues like dryness and discomfort.
- A survey of 489 participants showed a high prevalence of ocular symptoms linked to isotretinoin use, with notable findings including a majority experiencing soreness and blurred vision.
- Key risk factors for worsening eye symptoms included contact lens use and higher isotretinoin dosages, suggesting the need for careful monitoring and preventive measures for patients at risk.
Recalcitrant Pustular Dermatosis Successfully Treated With Prolonged Isotretinoin Therapy.
Cureus
November 2024
Dermatology, Imperial Dermatology, Hollywood, USA.
Isotretinoin (13-cis-retinoic acid) is a well-established systemic treatment for moderate to severe acne vulgaris, renowned for its ability to target multiple contributors to acne pathogenesis. However, its therapeutic potential extends beyond conventional acne management. This case report highlights its efficacy in treating recalcitrant pustular dermatosis, a condition that proved resistant to standard therapies and posed significant diagnostic challenges.
View Article and Find Full Text PDFSerum Catestatin Levels in Patients with Acne Vulgaris: Single-Center Prospective Study.
Skin Appendage Disord
December 2024
Department of Dermatology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Introduction: Recent studies showed that antimicrobial peptides have an essential role in the pathogenesis of acne vulgaris. This study aims to investigate serum catestatin levels in acne vulgaris patients and focuses on the change in serum levels after systemic isotretinoin therapy.
Methods: This prospective study includes 101 acne vulgaris patients and 28 healthy controls.
Effective Management of Severe Epidermal Growth Factor Receptor Inhibitors-Induced Papulopustular Eruption With Low-Dose Isotretinoin and Corticosteroids.
Cureus
November 2024
Oncologic Dermatology, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.
Epidermal growth factor receptor inhibitors (EGFRi) are approved for treating various cancers. Given that EGFR signaling is crucial for normal skin growth and repair, inhibiting this pathway can disrupt skin homeostasis and integrity. Although generally well tolerated, molecularly targeted therapies can lead to skin-related adverse effects that significantly impact patients' quality of life, often resulting in treatment interruptions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!